ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs MXN
18.1495
0.21%
Brent Oil
84.39
0.00%
Bitcoin
64,129.65
-0.18%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. La Jolla Pharmaceutical Company (LJPC)

  7. La Jolla Pharmaceutical Company (LJPC) Noticias

LJPC

La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical Company
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LJPC
FechaHoraFuenteTítuloSímboloCompañía
14/02/202309:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
01/09/202207:39Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202211:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202211:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202216:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202208:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202208:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202208:20Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202208:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202207:55Business WireInnoviva Completes Acquisition of La Jolla PharmaceuticalNASDAQ:LJPCLa Jolla Pharmaceutical Company
15/08/202207:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202207:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202207:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LJPCLa Jolla Pharmaceutical Company
12/07/202205:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202214:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202206:32Business WireInnoviva to Acquire La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
05/07/202216:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
16/05/202215:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
09/03/202207:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
09/03/202207:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
17/11/202107:00Business WireLa Jolla Pharmaceutical Company Announces Share Repurchase PlanNASDAQ:LJPCLa Jolla Pharmaceutical Company
04/11/202107:45Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
02/11/202108:14Edgar (US Regulatory)Notification That a Class of Securities of Successor Issuer Is Demed to Be Registered Pursuant to Section 12(b) (8-k12b)NASDAQ:LJPCLa Jolla Pharmaceutical Company
10/09/202107:00Business WireTony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
05/08/202107:30Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
04/06/202106:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
04/06/202106:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/05/202116:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
07/05/202107:45Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 & Highlights Corporate ...NASDAQ:LJPCLa Jolla Pharmaceutical Company
08/03/202107:55Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three & Twelve Months Ended December 31, 2020 & Highlight...NASDAQ:LJPCLa Jolla Pharmaceutical Company
 Showing the most relevant articles for your search:NASDAQ:LJPC

Su Consulta Reciente

LSE
87LI
Higher Ed.1 A2s
USOTC
APCFF
Atlas Pearls (PK)
COIN
ASTRRUST
AstrCoin
LSE
04NT
Rams Mtg.'a2'32
AMEX
OPPX
Corbett Road Tactical Op...
NASDAQ
CSWCL
Capital Southwest
NASDAQI
CX502060GI
OMX Copenhagen Industria...
TSXV
BKMT
Blockmint Technologies
TG
9GM0
G Medical Innovations
BIT
P1TEC9
NLBNPIT1TEC9 20240621 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados